Niederlande -
Niederländisch -
myHealthbox
florbac®
bayer ag - waterdispergeerbaar granulaat - 15.000 iu/mg bacillus thuringiensis subsp. aizawai
Niederlande -
Niederländisch -
myHealthbox
monsoon® active
bayer ag - olie dispersie - 30 g/l foramsulfuron 15 g/l cyprosulfamide 10 g/l thiencarbazon-methyl
Niederlande -
Niederländisch -
myHealthbox
othello®
bayer ag - olie dispersie - 50 g/l diflufenican 2,5 g/l iodosulfuron-methyl-natrium 7,5 g/l mesosulfuron-methyl
Niederlande -
Niederländisch -
myHealthbox
pacifica® plus
bayer ag - waterdispergeerbaar granulaat - 50 g/kg amidosulfuron 10 g/kg iodosulfuron-methyl-natrium 30 g/kg mesosulfuron-methyl
Niederlande -
Niederländisch -
myHealthbox
roundup® evolution
bayer ag - vloeistof - 360 g/l glyfosaat
Niederlande -
Niederländisch -
myHealthbox
roundup® +
bayer ag - waterige oplossing - 360 g/l glyfosaat
Niederlande -
Niederländisch -
myHealthbox
tramat® 200
bayer ag - emulgeerbaar concentraat - 200 g/l ethofumesaat
Niederlande -
Niederländisch -
myHealthbox
viking®
bayer ag - waterige oplossing - 360 g/l glyfosaat
Niederlande -
Niederländisch -
myHealthbox
xentari®
bayer ag - waterdispergeerbaar granulaat - 15.000 iu/mg bacillus thuringiensis subsp. aizawai
Europäische Union -
Niederländisch -
EMA (European Medicines Agency)
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - longaandoening, chronisch obstructief - geneesmiddelen voor obstructieve aandoeningen van de luchtwegen, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.